Chargement en cours...
Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.
67Cu (t1/2 = 62 h) has demonstrated potential as a radionuclide for radioimmunotherapy, but limited availability severely restricts its widespread use. 64Cu (t1/2 = 12.8 h) has been shown to have comparable effectiveness in vitro and in vivo. The present study was undertaken to examine the therapeut...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1996
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC39110/ https://ncbi.nlm.nih.gov/pubmed/8692901 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|